Developments in the management of extremity soft tissue sarcomas.

about

Differential proteomic profiling of chordomas and analysis of prognostic factors.Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS).

P2860

Q33273896-5038618F-8350-4A67-B995-9690B48A921B Q35842863-ECF12BDA-0ABC-481B-A5A1-E7D1EBA14E68

P2860

Developments in the management of extremity soft tissue sarcomas.

Item

http://www.wikidata.org/entity/Q36353510

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Developments in the management of extremity soft tissue sarcomas.

@ast

Developments in the management of extremity soft tissue sarcomas.

@en

type

Item

label

Developments in the management of extremity soft tissue sarcomas.

@ast

Developments in the management of extremity soft tissue sarcomas.

@en

prefLabel

Developments in the management of extremity soft tissue sarcomas.

@ast

Developments in the management of extremity soft tissue sarcomas.

@en

P1476

Developments in the management of extremity soft tissue sarcomas.

@en

P2093

J Alexander Palesty

http://www.w3.org/2001/XMLSchema#string

William G Kraybill

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity.

Adenovirus-mediated interleukin 3 beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats.

Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Soft-tissue sarcomas: an update.

Potential gains using high-energy protons for therapy of malignant tumours.

P304

692-699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07357900500359984

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16377588

http://www.w3.org/2001/XMLSchema#string

Developments in the management of extremity soft tissue sarcomas.

about

P2860

P2860

Developments in the management of extremity soft tissue sarcomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698